123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease-Reference-Cited by-同舟云学术

123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease

Published:2018-10-04 Issue:11 Volume:33 Page:1734-1739
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Koros Christos¹²,Simitsi Athina¹²,Prentakis Andreas³,Beratis Ion²,Papadimitriou Dimitra⁴,Kontaxopoulou Dionysia²,Fragkiadaki Stella²,Papagiannakis Nikolaos²,Seibyl John⁵,Marek Kenneth⁵,Papageorgiou Sokratis G.²,Trapali Xenia Geronicola³,Stamelou Maria¹⁶⁷^ORCID,Stefanis Leonidas¹²

Affiliation:

1. 1st Neurology Clinic, Eginition Hospital; Athens University Medical School; Athens Greece

2. 2nd Neurology Clinic, Attikon Hospital; Athens University Medical School; Athens Greece

3. Nuclear Medicine Unit; Attikon Hospital; Athens Greece

4. Neurology Clinic; Henry Dunan Hospital; Athens Greece

5. Institute for Neurodegenerative Disorders; New Haven Connecticut USA

6. Neurology Clinic; Philipps University; Marburg Germany

7. Parkinson's Disease and Movement Disorders Department, HYGEIA Hospital; Athens Greece

Funder

Parkinson's Progression Markers Initiative (PPMI)

MULTISYN European Program

MULTISYN European programme